Phase III refers to a critical stage in the clinical trial process where a new drug or treatment is tested on a larger group of participants, typically ranging from several hundred to several thousand, to assess its efficacy and monitor adverse reactions. This phase aims to gather more comprehensive data on the drug's effectiveness compared to standard treatments or placebos and is essential for regulatory approval. Successful completion of Phase III can significantly impact the drug's future availability and usage in the general population.
congrats on reading the definition of Phase III. now let's actually learn it.